References
- Xi G, Keep RF, Hoff JT. Mechanisms of brain injury after intracerebral haemorrhage. Lancet Neurol. 2006;5:53–63.
- Arboix A, García-Eroles L, Massons J, et al. Haemorrhagic pure motor stroke. Eur J Neurol. 2007;14:219–223.
- Xue M, Del Bigio MR. Intracerebral injection of autologous whole blood in rats: time course of inflammation and cell death. Neurosci Lett. 2000;283:230–232.
- Arboix A, García-Eroles L, Massons J, et al. Hemorrhagic lacunar stroke. Cerebrovasc Dis. 2000;10:229–234.
- Aronowski J, Zhao X. Molecular pathophysiology of cerebral hemorrhage: secondary brain injury. Stroke. 2011;42:1781–1786.
- Yong HYF, Rawji KS, Ghorbani S, et al. The benefits of neuroinflammation for the repair of the injured central nervous system. Cell Mol Immunol. 2019;16:540–546.
- Xue M, Yong VW. Neuroinflammation in intracerebral hemorrhage: immunotherapies with high potential for translation. Lancet Neurol. 2020;19:1023–1032.
- Bai Q, Xue M, Yong VW. Microglia and macrophage phenotypes in intracerebral haemorrhage injury: therapeutic opportunities. Brain. 2020;143:1297–1314.
- Garton T, Keep RF, Wilkinson DA, et al. Intraventricular hemorrhage: the role of blood components in secondary injury and hydrocephalus. Transl Stroke Res. 2016;7:447–451.
- Li Q, Han X, Lan X, et al. Inhibition of neuronal ferroptosis protects hemorrhagic brain. JCI Insight. 2017;2:e90777.
- Bishop GM, Dang TN, Dringen R, et al. Accumulation of non-transferrin-bound iron by neurons, astrocytes, and microglia. Neurotox Res. 2011;19:443–451.
- Xiong XY, Wang J, Qian ZM, et al. Iron and intracerebral hemorrhage: from mechanism to translation. Transl Stroke Res. 2014;5:429–441.
- Gaasch JA, Lockman PR, Geldenhuys WJ, et al. Brain iron toxicity: differential responses of astrocytes, neurons, and endothelial cells. Neurochem Res. 2007;32:1196–1208.
- Okauchi M, Hua Y, Keep RF, et al. Effects of deferoxamine on intracerebral hemorrhage-induced brain injury in aged rats. Stroke. 2009;40:1858–1863.
- Gu Y, Hua Y, Keep RF, et al. Deferoxamine reduces intracerebral hematoma-induced iron accumulation and neuronal death in piglets. Stroke. 2009;40:2241–2243.
- Nakamura T, Keep RF, Hua Y, et al. Deferoxamine-induced attenuation of brain edema and neurological deficits in a rat model of intracerebral hemorrhage. J Neurosurg. 2004;100:672–678.
- Palmer C, Roberts RL, Bero C. Deferoxamine posttreatment reduces ischemic brain injury in neonatal rats. Stroke. 1994;25:1039–1045.
- Xue M, Mikliaeva EI, Casha S, et al. Improving outcomes of neuroprotection by minocycline: guides from cell culture and intracerebral hemorrhage in mice. Am J Pathol. 2010;176:1193–1202.
- Zhao F, Xi G, Liu W, et al. Minocycline attenuates iron-induced brain injury. Acta Neurochir Suppl. 2016;121:361–365.
- Lee SM, Yune TY, Kim SJ, et al. Minocycline reduces cell death and improves functional recovery after traumatic spinal cord injury in the rat. J Neurotrauma. 2003;20:1017–1027.
- Wang G, Li Z, Li S, et al. Minocycline preserves the integrity and permeability of BBB by altering the activity of DKK1-Wnt signaling in ICH model. Neuroscience. 2019;415:135–146.
- Cao S, Zheng M, Hua Y, et al. Hematoma changes during clot resolution after experimental intracerebral hemorrhage. Stroke. 2016;47:1626–1631.
- Okauchi M, Hua Y, Keep RF, et al. Deferoxamine treatment for intracerebral hemorrhage in aged rats: therapeutic time window and optimal duration. Stroke. 2010;41:375–382.
- Wu J, Yang S, Xi G, et al. Minocycline reduces intracerebral hemorrhage-induced brain injury. Neurol Res. 2009;31:183–188.
- Wu J, Hua Y, Keep RF, et al. Iron and iron-handling proteins in the brain after intracerebral hemorrhage. Stroke. 2003;34:2964–2969.
- Shehadah A, Chen J, Cui X, et al. Combination treatment of experimental stroke with niaspan and simvastatin, reduces axonal damage and improves functional outcome. J Neurol Sci. 2010;294:107–111.
- Wang Z, Wu L, You W, et al. Melatonin alleviates secondary brain damage and neurobehavioral dysfunction after experimental subarachnoid hemorrhage: possible involvement of TLR4-mediated inflammatory pathway. J Pineal Res. 2013;55:399–408.
- Guo F, Xu D, Lin Y, et al. Chemokine CCL2 contributes to BBB disruption via the p38 MAPK signaling pathway following acute intracerebral hemorrhage. FASEB. 2020;34:1872–1884.
- Zhou Y, Wang Y, Wang J, et al. Inflammation in intracerebral hemorrhage: from mechanisms to clinical translation. Prog Neurobiol. 2014;115:25–44.
- Adeoye O, Broderick JP. Advances in the management of intracerebral hemorrhage. Nat Rev Neurol. 2010;6:593–601.
- Xue M, Hollenberg MD, Yong VW. Combination of thrombin and matrix metalloproteinase-9 exacerbates neurotoxicity in cell culture and intracerebral hemorrhage in mice. J Neurosci. 2006;26:10281–10291.
- Chen L, Chen T, Mao G, et al. Clinical neurorestorative therapeutic guideline for brainstem hemorrhage (2020 China version). J Neurorestoratol. 2020;8(4):232–240.
- Selim M. Deferoxamine mesylate: a new hope for intracerebral hemorrhage: from bench to clinical trials. Stroke. 2009;40:S90–S91.
- Chiueh CC. Iron overload, oxidative stress, and axonal dystrophy in brain disorders. Pediatr Neurol. 2001;25:138–147.
- Wan J, Ren H, Wang J. Iron toxicity, lipid peroxidation and ferroptosis after intracerebral haemorrhage. Stroke Vasc Neurol. 2019;4:93–95.
- Zeng L, Tan L, Li H, et al. Deferoxamine therapy for intracerebral hemorrhage: a systematic review. PLoS One. 2018;13:e0193615.
- Hatakeyama T, Okauchi M, Hua Y, et al. Deferoxamine reduces neuronal death and hematoma lysis after intracerebral hemorrhage in aged rats. Transl Stroke Res. 2013;4:546–553.
- Cui HJ, He HY, Yang AL, et al. Efficacy of deferoxamine in animal models of intracerebral hemorrhage: a systematic review and stratified meta-analysis. PLoS One. 2015;10:e0127256.
- Bai Q, Sheng Z, Liu Y, et al. Intracerebral haemorrhage: from clinical settings to animal models. Stroke Vasc Neurol. 2020. DOI:https://doi.org/10.1136/svn-2020-000334.
- Zhang R, Bai Q, Liu Y, et al. Intracerebral hemorrhage in translational research. Brain Hemorrhages. 2020;1:13–18.
- Sheng Z, Liu Y, Li H, et al. Efficacy of minocycline in acute ischemic stroke: a systematic review and meta-analysis of rodent and clinical studies. Front Neurol. 2018;9:1103.
- Wells JE, Hurlbert RJ, Fehlings MG, et al. Neuroprotection by minocycline facilitates significant recovery from spinal cord injury in mice. Brain. 2003;126:1628–1637.
- Fouda AY, Newsome AS, Spellicy S, et al. Minocycline in acute cerebral hemorrhage: an early phase randomized trial. Stroke. 2017;48:2885–2887.
- Selim M, Foster LD, Moy CS, et al. Deferoxamine mesylate in patients with intracerebral haemorrhage (i-DEF): a multicentre, randomised, placebo-controlled, double-blind phase 2 trial. Lancet Neurol. 2019;18:428–438.